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ABSTRACT OF THESIS

THE ASSOCIATION BETWEEN DISTRESS AND BOTH SOCIAL SUPPORT AND
SOCIAL CONSTRAINT IN RECENTLY DIAGNOSED CANCER SURVIVORS:
A DAILY ASSESSMENT STUDY
This study evaluated two distinct aspects of social functioning (specifically, social
support and social constraint) in an attempt to increase understanding of its bidirectional
relationship with distress after cancer diagnosis. Participants in this intensive longitudinal
study were all recently diagnosed, first primary cervical or head/neck cancer survivors
(n=47). Data collection involved a comprehensive baseline assessment and 30-day period
of daily assessment (n=37) of key variables (i.e., social support, social constraint, and
distress). Data were analyzed using unconditional and conditional multilevel linear
models. None of the variables changed significantly over the 30-day period. On a typical
day, social constraint and distress were predictive of one another (ps < .001). Social
support and distress did not demonstrate a bidirectional relationship (ps > .05). In the
context of cancer adjustment and survivorship, future interventions for distress should
consider targeting social constraint and interventions for social constraint should consider
targeting distress.
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Chapter One: Introduction
Cancer Epidemiology in the United States
Every year, more than 1.5 million people will receive a cancer diagnosis in the
United States (American Cancer Society, 2017). In 2016, more than 15.5 million cancer
survivors are living in the United States, and this number was expected to grow in 2017
(American Cancer Society, 2017). Based on data from 2007 to 2013, the rate of 5-year
survival for all people diagnosed with cancer is 67% (National Cancer Institute, 2017),
but it should be appreciated that rates of survival differ significantly across both type
(e.g., breast versus lung) and stage (e.g., Stage IA versus IV) of disease. Regardless of an
individual’s survival rate, the quality of the cancer survivors’ life is well recognized as an
important outcome to consider.
Quality of Life (QOL)
QOL is a multidimensional concept (Cella & Nowinski, 2002) that includes an
individual’s perceptions of his or her physical, psychological, spiritual, and social
functioning (Ferrell & Hassey Dow, 1997). The aforementioned domains or factors
correspond to different aspects of QOL, all of which are theorized to be interdependent
(Ferrell & Hassey Dow, 1997). This means that, for example, a change in social
functioning is likely to cause or co-occur with a change in psychological functioning, and
vice versa. While there is a paucity of longitudinal research that explores the reciprocal
relationships among QOL factors (Bloom, Stewart, Johnston, Banks, & Fobair, 2001;
Ganz et al., 2003; Hagedoorn, Sneeuw, & Aaronson, 2002; Ramchand, Marshall, Schell,
Jaycox, & Corporation, 2008), there is a sizeable body of cross-sectional research that
demonstrates significant associations among the factors themselves and/or significant
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relationships between overall QOL and its underlying factors (for example, see Cotton,
Levine, Fitzpatrick, Dold, & Targ, 1999; Rippentrop, Altmaier, Chen, Found, & Keffala,
2005; Wenzel et al., 2005; Zenger et al., 2010).
Cancer Survivors’ QOL
Most research suggests cancer survivors report worse QOL than individuals
without a cancer history (Arndt, Merx, Stegmaier, Ziegler, & Brenner, 2004; Burris &
Andrykowski, 2011; Jephcott, Paltiel, & Hay, 2004; Lee et al., 2011; LeMasters,
Madhavan, Sambamoorthi, & Kurian, 2013; Richardson, Wingo, Zack, Zahran, & King,
2008) though some studies show no significant difference between people with and
without a cancer history (Bradley, Rose, Lutgendorf, Costanzo, & Anderson, 2006;
Wettergren, Bjorkholm, Axdorph, Bowling, & Langius-Eklof, 2003). Nonetheless, cancer
survivors’ QOL (see Figure 1.1) is known to vary across individuals and across time
(Andrykowski, Lykins, & Floyd, 2008; Helgeson, Snyder, & Seltman, 2004). Some of
the individual difference variables that explain QOL differences among cancer survivors
include age (Roland, Rodriguez, Patterson, & Trivers, 2013; So et al., 2012), gender
(LeMasters et al., 2013), race (Janz et al., 2009), type of diagnosis (Bloom et al., 2001),
type of treatment (Zeng, Ching, & Loke, 2011), and behavioral factors (Duijts, Faber,
Oldenburg, Beurden, & Aaronson, 2011; Zeng et al., 2011). Although it seems that most
cancer survivors’ overall QOL improves with time – even if it does not return to their
pre-cancer baseline (Andrykowski et al., 2008; Hsu, Ennis, Hood, Graham, & Goodwin,
2013) – the sub-factors of QOL can show a different pattern of change or no change at all
(Hsu et al., 2013; Koczywas et al., 2013; So et al., 2012). Thus, the QOL of cancer
survivors is quite complex.
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The large body of research on cancer survivors’ QOL includes studies that focus
on describing the nature and course of one or more individual factors. The literature
shows that cancer survivors’ overall physical functioning (e.g., nausea, fatigue, and sleep
problems) may improve after treatment (Bloom, Petersen, & Kang, 2007), but some late
effects of treatment (e.g., cognitive impairment, pain, and cardiovascular events) can
occur in this population (Ahles et al., 2002; Kenyon, Mayer, & Owens, 2014). Physical
functioning is often correlated with psychological functioning (Loeb & Jonas, 2015;
Ramchand et al., 2008; Wilson & Cleary, 1995), which includes symptoms of anxiety,
depression, and other indicators of distress 1 as well as positive outcomes like life
satisfaction (Ferrell, Grant, Funk, Otis-Green, & Garcia, 1998; Wilson & Cleary, 1995).
Psychological functioning is also known to change over time (Bloom et al., 2007;
Stiegelis, Ranchor, & Sanderman, 2004), a finding that will be discussed in more depth
later. Spiritual functioning pertains to the ability to derive meaning from the cancer
experience, be hopeful, and perceive a sense of purpose in life (Brady, Peterman, Fitchett,
Mo, & Cella, 1999; Ferrell et al., 1998; Sterba et al., 2014; Wenzel et al., 2005). A study
of lung cancer survivors’ spiritual needs found that it fluctuates in the last year of life,
and that spiritual distress is greatly associated with four key events along the cancer
continuum (specifically, diagnosis, treatment completion, disease progression, and
terminal illness; Murray et al., 2007). Although this study only included lung cancer
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The National Comprehensive Cancer Network defines “distress” as “a multifactorial unpleasant
emotional experience… that may interfere with the ability to cope effectively with cancer, its physical
symptoms and its treatment” (National Comprehensive Cancer Network, 2013, pg. DIS-3, emphasis
added). As “distress” and “psychological distress” are viewed here as interchangeable, “distress” will be
used for sake of brevity.
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survivors, it is likely the results may generalize to other cancer survivors. Finally, social
functioning primarily deals with an individual’s social roles and relationships (Bloom et
al., 2007; Ferrell, Grant, Funk, Otis-Green, & Garcia, 1997). Social-related concerns
(e.g., worry about finances or job security, or fear about one’s daughter developing
cancer) may persist beyond the completion of cancer treatment (Beckjord et al., 2014;
Ferrell et al., 1997), and may differ by gender, age, race, and ethnicity (Bourjolly,
Kerson, & Nuamah, 1999; Carver, Smith, Petronis, & Antoni, 2006; Hammerlid & Taft,
2001). Although prior research largely treats the various QOL factors as unique, it is
expected that disruption or improvement in one factor will affect one or more of the
others factors (Bloom et al., 2007), a dynamic relationship that can only be fully tested by
use of longitudinal research designs.
Compared to the physical and psychological aspects of cancer survivors’ QOL,
the spiritual and social aspects have received little attention. In particular, social
functioning deserves greater clinical and research attention since cancer is a disease that
affects the whole family, not just the individual who receives the diagnosis (BallardReisch & Letner, 2003; Edwards & Clarke, 2004; Mantani et al., 2007; Traa, De Vries,
Bodenmann, & Den Oudsten, 2015). Another reason to better understand the social
functioning of cancer survivors is because it could explain (at least in part) why other
aspects of QOL, such as psychological functioning, vary across people and time. Given
the fact that social functioning is a relatively understudied, but potentially influential
factor for cancer survivors, it will be the focus herein.
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Social Functioning I
Social functioning corresponds to a wide array of social components (e.g.,
occupation/workplace productivity, community engagement, relationship quality, and
parental, familial, and other social roles; Hirschfeld et al., 2000), and is related to how
individuals interact with the environment and engage in social relationships (Bosc, 2000).
Among cancer survivors, various indicators of social functioning demonstrate the ability
to impact both health behavior and QOL outcomes (Edwards & Clarke, 2004;
Pasipanodya et al., 2012; Roland et al., 2013). To summarize, studies with cancer
survivors that show better social functioning is associated with better treatment adherence
(DiMatteo, 2004), higher levels of physical activity (Mosher et al., 2009), less distress
(Jim & Andersen, 2007; Mantani et al., 2007; Roland et al., 2013), less physical pain
(Roland et al., 2013), and better overall health (Roland et al., 2013). Although social
functioning appears to have a strong influence on important outcomes among cancer
survivors, a closer look at the extant research shows some inconsistency across studies.
Some studies have found that cancer survivors have poorer social functioning than the
general population (Arndt et al., 2004; Efficace et al., 2008; Vironen, Kairaluoma, Aalto,
& Kellokumpu, 2006) while other studies have not found this difference (Dorval,
Maunsell, Deschbnes, Brisson, & Masse, 1998; McLarty et al., 1997; van Tulder,
Aaronson, & Bruning, 1994; Wenzel et al., 2005). Similarly, some studies find social
functioning improves with time (Chan, Ng, Ngan, & Wong, 2003; King, Kenny, Shiell,
Hall, & Boyages, 2000) while others do not (Bozec et al., 2008; de Graeff et al., 2000b;
Ronis, Duffy, Fowler, Khan, & Terrell, 2008). Finally, some studies find social
functioning is associated with the overall QOL of cancer survivors (Edwards & Clarke,
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2004; Karnell, Christensen, Rosenthal, Magnuson, & Funk, 2007; Pasipanodya et al.,
2012; Roland et al., 2013; Wenzel et al., 2005), whereas other studies do not find a
significant association between these variables (Kemmler et al., 1999; King et al., 2000).
A plausible explanation for all of this inconsistency is that social functioning is a
multidimensional construct that includes a wide range of domains, not all of which
operate in the same way or carry the same significance across outcomes (Muzzatti &
Annunziata, 2012).
Since social functioning is multidimensional and its various sub-components may
differentially impact any and all outcomes of interest (Hirschfeld et al., 2000), the
proposed study will focus not on the broader construct, but on two sub-components
thought to be particularly important for cancer survivors. Herein, the focus is on the
social factors of social support and social constraint. By focusing on these factors, the
proposed study will address both a positive and negative dimension of social functioning
(social support and social constraint, respectively), and provide important information
about which specific aspects of social functioning explain the distress of cancer
survivors.
Social Functioning II: Social Support
Definitions and measurement. Social support is normally considered a positive
dimension of social functioning (Mallinckrodt, Armer, & Heppner, 2012; Nilsson et al.,
2013). Although social support does not have a universally agreed upon definition
(Uchino, 2006; Walsh & Connelly, 1996), it may be understood as the emotional,
instrumental, and informational support provided by an individual’s social network
(Dakof & Taylor, 1990). In addition, in some studies, social support is divided into
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structural and functional support, where structural support refers to the number of people
in ones social network and functional support refers to the nature, quality, and function of
the support components (Nausheen, Gidron, Peveler, & Moss-Morris, 2009). The
aforementioned variability in definitions and measurement of social support likely
contributes to a lack of consensus concerning how, for whom, and when social support
influences other aspects of QOL or any other outcome (Nausheen et al., 2009; Uchino,
2006). For example, perceived social support in long-term cancer survivors is sometimes,
but not always related to posttraumatic growth (Schroevers, Helgeson, Sanderman, &
Ranchor, 2010), and lower perceived social support is more strongly related to colon
cancer risk in African American men than Caucasian men (Kinney et al., 2003). The
proposed study will focus on the amount of perceived functional social support since 1) it
is most consistently related to various aspects of QOL (Luszczynska, Pawlowska,
Cieslak, Knoll, & Scholz, 2013) and 2) it has a broad research base from which to make
firm hypotheses.
Significance. Social support is positively linked to physical functioning
(Luszczynska et al., 2013) and treatment adherence (Spiegel, 1997), and negatively
related to cancer progression (Nausheen et al., 2009). Social support also seems to help
cancer survivors cope with anger, stress, depression, and other indicators of
psychological maladjustment (Holland & Holahan, 2003; Jim & Jacobsen, 2008;
Koopman, Hermanson, Diamond, Angell, & Spiegel, 1998; Luszczynska et al., 2013;
Nausheen et al., 2009; Salonen et al., 2012; Turner-Cobb, Sephton, Koopman, BlakeMortimer, & Spiegel, 2000). It is also related to workplace productivity, an outcome
which may reflect a “return to normal” after cancer diagnosis (Nilsson et al., 2013).
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Finally, greater social support predicts better overall QOL (Salonen et al., 2012; So et al.,
2012). In sum, social support is an important predictor of several essential outcomes in
cancer survivors, including QOL.
Social Functioning III: Social Constraint
Definitions and measurement. In contrast to social support, social constraint
reflects a negative aspect of social functioning. Lepore and Revenson (2007) define
social constraint as “both objective social conditions and individuals’ construal of those
conditions that lead individuals to refrain from or modify their disclosure of stress- and
trauma-related thoughts, feelings, or concerns” (pg. 3). Social constraint is present when
someone has an unsupportive partner, friend, or family member that responds negatively
with criticism, avoidance, or conflict (Badr & Carmack Taylor, 2006). Of note, social
constraint can be present in what is perceived to be a generally supportive relationship
(Kratz et al., 2010; Pasipanodya et al., 2012), and it may even happen unintentionally
(Pasipanodya et al., 2012). For example, a caregiver can behave in a way intended to
communicate openness and interest, but the cancer survivor does not perceive it as such
(Pasipanodya et al., 2012). Since social constraint can exist within the context of a
generally positive relationship, it is important that studies of social support also measure
social constraint. Unlike the research on social support, there is one measure of social
constraint that is widely used across studies on the topic: the Social Constraints Scale
(Adams, Winger, & Mosher, 2015; Lepore & Ithuarte, 1999; Lepore & Revenson, 2007;
Pasipanodya et al., 2012). The proposed study will therefore measure social constraint
with the aforementioned scale, so the results of this study can more easily be compared to
those from prior studies with cancer survivors.
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Significance. Within the context of any relationship, people who experience social
constraint are less likely to share the events of their daily life (Pasipanodya et al., 2012)
and therefore compromise their cognitive and emotional processing of particularly
stressful events (Badr & Carmack Taylor, 2006; Lepore & Revenson, 2007). Thus, social
constraint may negatively impact both individual well-being and the quality of ones
relationship with others (i.e., relational well-being; Edwards & Clarke, 2004; Lepore &
Revenson, 2007; Pasipanodya et al., 2012). In cancer survivors, social constraint has
negative implications for self-esteem (Pasipanodya et al., 2012), and some indicators of
distress (Cordova, Cunningham, Carlson, & Andrykowski, 2001), and it is expected to
have a detrimental impact on overall QOL.
Psychological Functioning I
Like social functioning, psychological functioning is a complex, multidimensional
construct (Andrykowski et al., 2008; Ferrell et al., 1998). After cancer diagnosis, it is
expected that most individuals will experience some degree of psychological disturbance
(Andrykowski et al., 2008). In many cases, cancer survivors’ psychological functioning is
expected to improve over time (Andrykowski et al., 2008; Helgeson et al., 2004). For
those who experience an improvement, three outcomes are possible: 1) a return to a precancer baseline, or “recovery”, 2) an overall decrease in psychological functioning
compared to the pre-cancer baseline, or “impairment”, and 3) an overall increase in
psychological functioning compared to the pre-cancer baseline, or “growth”
(Andrykowski et al., 2008). Thus, the psychological functioning of cancer survivors can
follow any number of paths, some reflecting positive change, others reflecting negative
change, and still others reflecting no change at all (i.e., “resilience”).
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Psychological functioning includes positive and negative aspects, and it is
important to note that said aspects are not mutually exclusive (Cordova et al., 2001). As a
higher-order construct, psychological functioning is related to subjective reports of both
health status (Ganz et al., 2003) and overall QOL (Tomich & Helgeson, 2012; Wenzel et
al., 2005; Zenger et al., 2010). The positive dimensions of psychological functioning
correspond to reports of enhanced psychological adjustment and well-being, which are
often subsumed by the concept of posttraumatic growth (Andrykowski et al., 2008).
Other positive psychological outcomes include benefit finding, happiness, self-esteem,
and life satisfaction (Andrykowski et al., 2008). While such positive outcomes are indeed
possible and clinically significant after cancer diagnosis, most research focuses on the
negative aspects of psychological functioning. Negative psychological functioning
mostly corresponds to reports of distress, which includes the outcomes of anxiety, worry,
depression, sadness, anger, fear, and panic (Andrykowski et al., 2008; Ferrell et al.,
1998). Since distress is a common experience for many cancer survivors (for reviews, see
Andrykowski et al., 2008; Carlson, Waller, & Mitchell, 2012; Jim & Jacobsen, 2008;
Walker et al., 2012), and it too has clinically significant implications for cancer survivors
(Andersen et al., 2008; Greer, Pirl, Park, Lynch, & Temel, 2008; Weitzner, Meyers,
Stuebing, & Saleeba, 1997; Zenger et al., 2010), the focus of the proposed study is on
distress.
Psychological Functioning II: Distress
Definitions and measurement. The experience of cancer – from diagnosis through
treatment, recovery, and end-of-life – is widely accepted as a chronic stressor, and as
such, it is common for cancer survivors to experience some degree of distress at some
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point along the continuum of care (Andrykowski et al., 2008; Carlson et al., 2012).
Distress ranges from normal feelings of vulnerability and sadness to problems that
becomes disabling (National Comprehensive Cancer Network, 2013). There are a
multitude of distress measures in the literature, many of which are commonly used with
cancer survivors (e.g., Brief Symptom Inventory, General Health Questionnaire, and
Distress Thermometer; Carlson et al., 2012). The Distress Thermometer – a single-item
scale that taps overall distress (National Comprehensive Cancer Network, 2013) – is one
of the most widely recommended for use with cancer survivors due to its simplicity,
brevity, and predictive value (Carlson et al., 2012). Consequently, the proposed study
will use the Distress Thermometer.
Significance. A diagnosis of cancer increases the likelihood that someone
experiences distress, even if that distress is time-limited. Around 35% of cancer survivors
experience high levels of distress, with variation in the prevalence of “clinically
significant” distress across the various types of cancers (Zabora, Brintzenhofeszoc,
Curbow, Hooker, & Piantadosi, 2001). Among cancer survivors, distress has a
detrimental impact on treatment compliance (DiMatteo, Lepper, & Croghan, 2000),
number of medical visits (i.e., more visits), and cost of medical care (i.e., higher costs;
Carlson & Bultz, 2004). Furthermore, distress predicts or is correlated with poorer social
functioning (Badr, Laurenceau, Schart, Basen-Engquist, & Turk, 2010; Pasipanodya et
al., 2012; Zakowski et al., 2003) and overall QOL in cancer survivors (Brown, Kroenke,
Theobald, Wu, & Tu, 2010; Weitzner et al., 1997; Zenger et al., 2010). Due to its high
prevalence and significance, more research should explore modifiable risk and protective
factors for distress.
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Current Study Aims
Aim 1. Measure and describe change over time in the social functioning and
distress of recently diagnosed cancer survivors. Three hypotheses correspond to this aim:
a) social support will decline significantly over time; b) social constraint will not change
significantly over time, and c) distress will not change significantly over time.
Aim 2. Examine whether there is a longitudinal, bidirectional relationship between
social functioning and distress in recently diagnosed cancer survivors. Three hypotheses
correspond to this aim: a) greater social support will predict lower levels of distress, b)
greater social constraint will predict higher levels of distress, and c) greater distress will
predict lower levels of support and higher levels of social constraint.
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Figure 1
Quality of Life in Cancer Survivors (adapted from Ferrell, Dow & Grant, 1995)

Physical Functioning
•The control of cancer symptoms,
and maintenance of function and
independence
• Functional Ability
• Strength
• Sleep and Fatigue
• Appetite
• Constipation
• Nausea

Psychological Functioning

Spiritual Functioning
• The ability to maintain hope and
get meaning from cancer that is
characterized by uncertainty
• Meaning of Illness
• Religiosity
• Transcendence
• Hope
• Uncertainty
• Positive Changes

QOL

Social Functioning
• The role cancer survivors play in
their social network, and their
social structure and relationships
• Relationship Distress
• Roles and Relationships
• Appearance
• Isolation
• Affection/Sexual Function
• Employment
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• The seeking of a sense of control
over cancer that is usually
characterized by emotional
distress and fear of the unknown
• Perceived Control
• Anxiety
• Depression
• Fear of Recurrence
• Worry
• Happiness

Chapter Two: Methods
Participants
Participants were adults with recently diagnosed, first primary cervical or
head/neck cancer (n=47). Since this study is part of a larger study of tobacco use after a
new cancer diagnosis, all participants were current tobacco users based on 30-day point
prevalence at study enrollment. Other inclusion criteria were as follows: 1) pathologyconfirmed cervical cancer or head and neck squamous cell carcinoma; 2) cancer
diagnosis in the 6 months prior to enrollment; 3) age 21 or older at enrollment; and 4)
ability to read, write, and understand English. Exclusion criteria were: 1) prior cancer
diagnosis other than non-melanoma skin cancer; 2) cognitive or psychiatric impairment
that would interfere with the ability to provide informed consent or complete study
procedures; 3) unreliable phone access (i.e., no landline or cellular phone for personal
use); and 4) pregnancy or plan to be pregnant within 6 months.
Procedure
Recruitment and enrollment. Participants were recruited through the University
of Kentucky Markey Cancer Center in Lexington, KY. Participants with cervical and
head/neck cancer were recruited through the Gynecologic Oncology Clinic and
Multidisciplinary - Head and Neck Clinic, respectively. In consultation with attending
oncologists and nurses, research staff accessed and reviewed the electronic medical
records of individuals scheduled for an initial evaluation to conduct a preliminary screen
for eligibility. Those individuals not ruled out on the basis of information in their
electronic medical record were then screened for eligibility either in person or over the
phone. Eligible persons were briefly informed about the study procedures and asked if
they would like to participate. If interested in study participation, these persons began the
14

process of informed consent. Individuals were “enrolled” into the study upon attainment
of written informed consent and a signed HIPAA authorization. Prior to the
implementation of this study, it was approved by the UK Institutional Review Board.
Baseline assessment. Shortly after enrollment, a baseline assessment was
conducted. Participants had the option to complete the baseline assessment via a paperand-pencil questionnaire (mail) or interview with research staff (over the phone or inperson). If the questionnaire format was used for this assessment, participants received
and returned the questionnaire by mail at no cost to them. The phone interview format
was assisted by Research Electronic Data Capture (REDCap, Harris et al., 2009), and the
in-person interviews were administered in clinic. Most participants completed this
assessment via questionnaire (68.09%, n=32), with 17.02% (n=8) completing it by phone,
and 14.89% (n=7) completing it in-person. Regardless of the method of data collection,
the baseline assessment took 30-45 minutes to complete, and all data were entered and
stored securely in a REDCap database.
Daily assessment. After the baseline was completed, participants were scheduled
to begin a 30-day period of daily assessment (i.e., 30 consecutive days of assessment).
The preferred mode of data collection for this assessment was via phone. Instead of a
conventional phone interview that requires interaction with research staff, the daily
assessment was administered through the use of an interactive voice response (IVR)
system, which is described in more detail below. IVR is an optimal approach to data
collection since the data are securely collected and stored with a date and time stamp all
in real time. Additionally, IVR can be used with any phone without the need for a new
device or modification of an existing device (as is the case with some methods of daily
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assessment, such as ecological momentary assessments). Finally, IVR has good
acceptability and satisfaction among consumers (Corkrey & Parkinson, 2002; Mundt,
1997), in part because it is viewed as more confidential than standard interviews (Corkrey
& Parkinson, 2002; Kobak, Greist, Jefferson, & Katzelnick, 1996). In sum, IVR provides
a reliable and valid means of data collection within an ecological framework.
The IVR system used for this study was proactive, which means participants
received an automated call at the same time each afternoon or evening, with the precise
time dependent upon the preference of a given participant. If participants did not answer
the call, the IVR system tried again two more times that same day according to a pre-set
schedule of calls. Furthermore, participants also had the option to call into the IVR
system via a 1-800 toll-free number in order to complete an assessment missed earlier in
the day, or to proactively complete an assessment they would otherwise miss (e.g., if
social plans conflict with their regular call schedule). The assessment itself consisted of
20 questions in total, only five of which were of relevance to the proposed study (see
“Daily assessment” in the Measures section below). In its entirety, this assessment took
5.72 ± 1.09 (M ± SD) minutes to complete. During the call, participants responded to the
IVR system via their phone’s keypad, and were able to repeat any question as needed
before responding.
As with the baseline assessment, participants had the option to complete this
assessment via a paper-and-pencil questionnaire. Once again, if this format was used,
participants received and returned the questionnaires by mail at no cost to them. Data
obtained via questionnaire was entered and stored securely in the same system used for
data collected via phone. While the use of a paper questionnaire is not ideal for daily
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assessments, it was used here in an attempt to lessen the amount of missing data due to
reasons unrelated to the research question (i.e., the practical challenges of coping with a
chronic disease, rigorous medical procedures, and possibly even hospitalization during
the course of the daily assessments). In the end, just under half of the daily assessments
were completed via phone (44.73%, n=395).
Compensation. Participants received $20 for completion of the baseline
assessment. The compensation rate for the daily assessment was consistent with prior,
similar studies and was designed to increase compliance with study procedures (Helzer,
Badger, Rose, Mongeon, & Searles, 2002; Hughes et al., 2013; Peters & Hughes, 2009;
Searles, Helzer, Rose, & Badger, 2002; Tucker et al., 2007). Thus, participants were paid
$2 for each assessment and an additional $5 for each week where all assessments were
completed; participants received compensation on a weekly basis for these assessments in
order to maintain interest in this aspect of the study. In total, participants could earn up to
$80 for the daily assessment. For both types of assessments, participants were paid via
check.
Measures
Demographics. Standard items for assessment of demographic background (e.g.,
age, race, and relationship status) were used. Items were largely taken verbatim from the
Behavioral Risk Factors Surveillance System survey (Centers for Disease Control and
Prevention, 2011), which is a population-based health survey done annually in the United
States.
Chart review. A review of each participant’s electronic medical record at the
University of Kentucky was done in order to describe the clinical characteristics of the

17

sample. These variables were extracted from each medical record, if available: 1) date of
diagnosis; 2) age at diagnosis; 3) cancer site (e.g. larynx, oral cavity, cervical, etc.); 4)
cancer stage; 5) date of treatment initiation; and 6) nature of treatment (e.g., surgery,
radiation).
Social support. Social support at baseline was primarily measured with the DukeUNC Functional Social Support Questionnaire (SSQ; Broadhead, Gehlbach, de Gruy, &
Kaplan, 1988), as it taps the dimensions of perceived affective support (e.g., support
obtained from people who give affection) and confidant support (e.g., support obtained
through opportunities to talk about personal problems and participate in activities). The
SSQ is often used in studies with cancer survivors (e.g., Breitbart et al., 2000; Broadhead
& Kaplan, 1991; Bultz, Speca, Brasher, Geggie, & Page, 2000; Herndon et al., 1999;
Osborne & Sinclair, 2004), which added to its suitability for this study. The 8-item SSQ
has good construct, concurrent, and discriminant validity, and is sensitive to change over
time (Broadhead et al., 1988). Example items include: “I get chances to talk to someone I
trust about my personal and family problems” and “I get invitations to go out and do
things with other people.” All items are measured on a scale from 1=much less than I
would like to 5=as much as I would like. Items are scored such that higher total scores on
the SSQ reflect greater perceived social support, and total score range from 8 to 40. The
coefficient alpha for the SSQ was 0.92.
In addition to the SSQ, participants were asked to identify the one person in their
life who they consider to be their main source of support. Response options included: 1)
spouse or other romantic partner; 2) child; 3) other family member; 4) close friend; 5)
member of religious organization; 6) neighbor; 7) other individual; or 8) no one (“I
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cannot think of a support person right now”). This last question is unique to the proposed
study, and was only used for descriptive purposes.
Social constraint. The 15-item Social Constraints Scale (SCS; Lepore & Ituarte,
1999) was used to measure social responses that inhibit the expression of cancer-related
thoughts, feelings, and experiences at baseline. This measure is the most valid and
commonly used indicator of social constraint in studies with cancer survivors (for a
review, see Adams et al., 2015; Lepore & Revenson, 2007). Instructions for the SCS
directed participants to consider the behavior of other in the past month, specifically
“with regard to [their] experience with cancer diagnosis and treatment.” Example items
include: “Minimize your problems,” “Act uncomfortable when you talked about your
experiences,” and “Tell you not to worry so much about your health.” All items were
measured on a scale from 1=never to 4=often. Items were scored such that higher scores
indicate greater social constraint, total score ranges from 15 to 60. Coefficient alpha for
the total score was 0.92.
Distress. Since distress presents in many ways, two measures of distress were
used at baseline: 1) a modified Distress Thermometer (DT) and 2) the Hospital Anxiety
and Depression Scale (HADS). Both of these measures are discussed below.
The 1-item DT (National Comprehensive Cancer Network, 2013), which is
commonly used with cancer survivors (e.g., Bevans et al., 2008; Chambers et al., 2013;
Hegel et al., 2008; Jacobsen et al., 2005), captures global distress on a 0 to 10 scale.
Distress in cancer survivors tends to change over time, and changes in DT scores are
positively correlated to changes in related measures (Gessler et al., 2008). Furthermore,
DT scores demonstrate good sensitivity and specificity when measured against other self-
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report measures or structured clinical interviews (Chambers, Zajdlewicz, Youlden,
Holland, & Dunn, 2014; Jacobsen et al., 2005; Patel, Sharpe, Thewes, Bell, & Clarke,
2011). In addition to continuous scores, a score of ³4 is typically used as a cut-off to
identify which cancer survivors may have clinically significant distress (Chambers et al.,
2014; Gessler et al., 2008; Jacobsen et al., 2005; Patel et al., 2011). The original measure
asks about distress experienced in the past week, but in the proposed study, participants
were only asked to consider their experiences on the day of the assessment. Additionally,
the DT used in this study is on a 0 to 9 scale in order to be consistent with other items in
the IVR assessment protocol. The item read as follows: “On a scale from 0 to 9, where 0
is no distress and 9 is extreme distress, how much distress did you experience today?”
The 14-item HADS (Zigmond & Snaith, 1983) measures anxiety and depressive
symptoms, and it too is often used with cancer survivors (e.g., Patel et al., 2011; Sellick
& Edwardson, 2007; Stafford et al., 2014). HADS anxiety and depression subscales have
good reliability and validity (Bjelland, Dahl, Haug, & Neckelmann, 2002). In cancer
survivors, the sensitivity and specificity for the anxiety, depression, and total scales falls
between 70% and 90% (Bjelland et al., 2002; Patel et al., 2011; Stafford et al., 2014; Jane
Walker et al., 2007). On the HADS, participants were asked to what extent each item (or
symptom) describes their feelings in the past week. Example items for anxiety and
depressive symptoms are “Worrying thoughts go through my mind” and “I have lost
interest in my appearance,” respectively. All items were answered on a scale from 0 to 3,
with the exact response option dependent upon the item. Items were scored such that
higher scores represent more severe anxiety and depressive symptoms. In addition to
continuous scores, cut-off scores can be used to identify clinically significant distress in
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cancer survivors, with cut-off scores that range from 7 to 11 for the depression and
anxiety subscales (Bjelland et al., 2002; Walker et al., 2007); in this study, a score ³11
was used as a cut-off. Coefficient alpha for the HADS total score was 0.89, and
coefficient alpha for the anxiety and depression subscale scores were 0.85 and 0.80,
respectively.
Daily assessment. The daily assessment consisted of five face valid items that as a
whole cover all key study variables (i.e., social support, social constraint, and distress).
Each item asked about participants’ experience the day of the assessment. Additionally,
all items were measured on a 0 to 9 scale; higher scores indicate more social support (the
only favorable outcome), more social constraint, and more distress. Social support and
social constraint were each measured with a single item while distress was measured with
three items that separately tap global distress, anxiety, and depressive symptoms (see
Table 2.1). The 1-item DT was used to measure distress in the daily assessment. Each of
the others items used in the daily assessment were adapted from, and/or reflects the basic
idea within, the more comprehensive measures described above.
Although it is generally preferred to use multi-item measures to assess complex
psychosocial constructs, daily assessment studies require brevity for compliance. The
items in this study, therefore, converge with the approach used in similar daily
assessment studies (e.g., (Searles et al., 2002; Zhou et al., 2009). To evaluate how well
the single items related to their corresponding multi-item measures at baseline, Pearson’s
r bivariate correlations were conducted. The single-item measures for social support
(r=.54, p<.001), anxiety symptoms (r=.73, p<.001), and depressive symptoms (r=.58,
p<.001) all exhibited strong and positive associations with their respective multi-item
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measures. In contrast, while the single-item social constraint measure was significantly
and positively correlated with its corresponding multi-item measure, the strength of the
relationship was relatively weak (r=.31, p=.04). Finally, and as noted above, there was
not a multi-item measure of distress available for comparison with the modified DT.
Data Analysis
Basic descriptive statistics (e.g., means, frequencies) and preliminary analyses
(e.g., bivariate Pearson’s r correlations) were used to describe the sample’s basic
characteristics and the relationships among all study variables at baseline. Statistical
analysis focused on data collected via the daily assessment.
As expected, missing data were present in the daily assessment due to the high
demand of study participation (i.e., daily assessments for one month) and the nature of
participants in the study (i.e., recently diagnosed cancer survivors undergoing and/or
recovering from arduous treatments). As a result, the possibility of bias was analyzed by
exploring baseline group differences on key study variables between participants with
(78.72%, n=37) and without (21.28%, n=10) daily assessment data; independent samples
t-tests and chi-square analyses were conducted, as appropriate. No significant differences
were found on any measure of participants’ demographic background (Table 2.2), clinical
characteristics (Table 2.3), social functioning (Table 2.4), or distress (Table 2.4). To
explore whether there were significant differences across participants who completed
varying amounts of the daily assessment, t-tests and chi-square analyses were again
conducted, as appropriate. With only one exception, no significant differences were
found on any of the aforementioned measures (data not shown). The exception was for
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the single-item anxiety measure: participants with higher anxiety levels completed a
smaller number of assessments (p=.04).
For the primary analyses, multilevel modeling was used due to the nature of
intensive longitudinal data (Bolger & Laurenceau, 2013; Singer & Willett, 2003). For
Aim 1, slopes of change in social functioning (i.e., social support and social constraint)
and distress from the first to the last day of the daily assessment were examined using a
series of unconditional random intercept and slope multilevel linear models. Linear
models were chosen because visual depiction of the raw data was not strongly suggestive
of a curvilinear pattern of change. For ease of interpretation, the first day of daily
assessment data was coded as zero (days coded as 0 – 29). For Aim 2, conditional
multilevel linear models were used to identify the bidirectional relationship between dayto-day changes in social functioning and distress. In these models, if a predictor
variable’s slope of change did not significantly differ across the 30 days, person-centered
means scores on the predictor were used in the model. Further, if the dependent variable’s
slope did not change significantly over time in the unconditional models, time was recentered at the mid-point of the daily assessment (i.e., day 15) to establish a “typical day”
for the dependent variable. For both aims, restricted maximum likelihood estimation was
used to handle missing data, and data analysis was done with version 24 of the Statistical
Package for the Social Sciences (SPSS) (IBM Corp., 2017).
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Table 2.1
Daily Assessment Measures
Variable
Social Support
Social Constraint

Distress
Global distress
Anxiety symptoms
Depressive symptoms

Item
“How much support did
you receive from others
today?”
“How often did others
dismiss your concerns
when you tried to express
them today?”

Scale
0=none to 9=a great deal

“How much distress did
you experience today?”
“How often did you feel
worried, tense, or anxious
today?”
“How often did you feel
sad, blue, or depressed
today?”

0=no distress to 9=extreme
distress
0=never to 9=almost all the
time
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0=never to 9=almost all the
time

0=never to 9=almost all the
time

Table 2.2
Demographic Characteristics of the Sample
Daily assessment data
Variables

Total sample
(n=47)
56.43 ± 7.42

Yes (n=37)

No (n=10)

p

Age in years 1
55.89 ± 8.01 58.40 ± 4.43 .35
Gender
Male
63.83
59.46
80.00
.23
Female
36.17
40.54
20.00
Race
White, non-Hispanic
95.74
94.59
100.00
.75
African American
2.13
2.70
0.00
Hispanic/Latino
0.00
0.00
0.00
Other
2.13
2.70
0.00
Relationship status
Single, never married
8.51
8.11
10.00
.89
Divorced, widowed,
44.68
43.24
50.00
separated
Married or partnered
46.81
48.65
40.00
Educational attainment
Less than high school
graduate or
34.04
32.43
40.00
.87
equivalent
High school graduate or
40.43
40.54
40.00
equivalent
Some college or college
25.53
27.03
20.00
graduate
Employment
Employed
21.28
21.62
20.00
.92
Unemployed
12.77
13.51
10.00
Disabled
51.06
48.65
60.00
2
Other
14.89
16.22
10.00
Annual household income
Less than $10,000
40.43
40.54
40.00
.72
$10,000 to $19,999
27.66
24.32
40.00
$20,000 to $34,999
19.15
21.62
10.00
$35,000 or more
12.77
13.51
10.00
Note. Data are percentages unless otherwise noted. Percentages may not sum to 100.0 due
to rounding. 1 Data are means ± standard deviations. 2 Other denotes homemaker, student,
or retired.
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Table 2.3
Clinical Characteristics of the Sample
Daily Assessment Data
Yes (n=37) No (n=10)
p
.21
1.27 ± 1.88 0.50 ± .53
.31
1.05 ± 1.51 0.25 ± .50

Variable
Total Sample (n=47)
Months since diagnosis 1
1.11 ± 1.71
Months since treatment 1
0.32 ± 1.42
Cancer site
Cervical
12.77
16.22
0.00
.60
Oral Cavity
10.64
8.11
20.00
Larynx
34.04
32.43
40.00
Nasal Cavity
8.51
8.11
10.00
Pharynx
27.66
27.03
30.00
Sinus
6.38
8.11
0.00
Histology
Squamous cell
97.87
97.30
100.00
.60
carcinoma
Adenocarcinoma 2
2.13
2.70
0.00
Cancer stage
0 or In situ
4.44
5.56
0.00
.53
I
13.33
13.89
11.11
II
15.56
19.44
0.00
III
15.56
13.89
22.22
IV or metastatic
51.11
47.22
66.67
Treatment received
Yes
91.50
94.44
90.00
.61
No
4.26
2.78
10.00
Not started yet treatment
4.26
2.78
0.00
Treatment type 3
Surgery only
16.28
17.65
11.11
.75
Radiation only
9.30
11.76
0.00
Surgery and radiation or
13.95
11.76
22.22
chemotherapy
Radiation and
41.86
41.18
44.44
chemotherapy
Surgery, radiation, and
18.60
17.65
22.22
chemotherapy
Note. Data are percentages unless otherwise noted; 1 Data are means ± standard
deviations. 2 Only applicable to cervical cancer. 3 Data are for participants whose
treatment was documented in their medical record at the time of data analysis (n=43).
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Table 2.4
Descriptive Information for Key Study Variables
Daily Assessment Data
Variables

Total Sample
(n=47)

Multi-item measures
Social Support

31.25 ± 9.00

Social Constraint

30.22 ± 11.01

HADS Total
14.37 ± 8.54
Anxiety
7.91 ± 5.01
Depression
6.49 ± 4.36
Single item measures
Social Support
5.45 ± 3.50
Social Constraint
2.32 ± 3.35
Distress
4.32 ± 2.96
Anxiety
4.38 ± 3.31
Depression
3.57 ± 3.49
Note. Data are means ± standard deviations.
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Yes (n=37)

No (n=10)

p

31.54 ± 9.09
29.31 ±
10.42
13.24 ± 8.04
7.22 ± 4.92
6.03 ± 4.04

30.11 ± 9.06
33.78 ±
13.15
19.00 ± 9.49
10.78 ± 4.55
8.20 ± 5.27

.68

5.89 ± 3.50
2.65 ± 3.62
4.49 ± 2.98
4.35 ± 3.22
3.49 ± 3.53

3.80 ± 3.12
1.10 ± 1.66
3.70 ± 2.95
4.50 ± 3.84
3.90 ± 3.51

.09
.20
.46
.90
.74

.28
.07
.06
.17

Chapter Three: Results
Preliminary Analyses
Sample demographic and clinical characteristics. A total of 47 participants
completed the baseline assessment, and the details of their demographic and clinical
background can be found in Tables 2.2 and 2.3. As a brief summary, participants’
average age was 56.43 ± 7.42 years old. Most participants were male (63.83%, n=30) and
identified themselves as White non-Hispanic (95.74%, n=45). Just under half of the
participants reported being in a relationship (46.81%, n=22). The educational attainment
of the sample was low, with only 25.53% (n=12) reporting college education. Related to
their employment status, most participants reported being on disability (51.06%, n=24),
with only 21.28% (n=10) currently employed. Most participants reported an annual
household income lower than $20,000 (67.79%, n=32).
The sample consists of newly diagnosed cancer survivors, as indicated by the fact
that participants’ average number of months since diagnosis at baseline was 1.11 ± 1.71.
Most participants were diagnosed with head/neck cancer (87.23%, n=41). More than half
of the participants were diagnosed with stage IV or metastatic cancer (51.11%, n=23).
Most participants received some type of cancer treatment (93.48%, n=43), with many
having multi-modal treatment (74.41%, n=32). Three participants died at some point
during the course of the study (6.38%). Other details about participants’ clinical
characteristics may be found in Table 2.3.
Social functioning at baseline. Participants’ main source of support primarily
came from their familial relationships: spouse or partner (43.48%, n=20), child (30.43%,
n=14), and other family member (13.04%, n=6); other sources included close friends,
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religious groups, and health professionals (13.04%, n=6). Participants’ scores on the
SSQ, SCS and single-item social functioning measures are shown in Table 2.4. Given the
nature of the skew, participants tended to report high levels of social support and low
levels of social constraint.
Distress at baseline. Participants’ continuous scores on the modified DT, HADS,
and single-item distress measures are shown in Table 2.4; the data show a fairly normal
distribution for each of the distress measures. In terms of the clinical significance of
participants’ distress scores, 63.83% (n=30) of the participants met the criterion for
significant distress on the DT. On the HADS anxiety and depression subscales, 30.43%
(n=14) and 14.89% (n=7) of the participants reported significant anxiety and depressive
symptoms, respectively.
The three single-item measures of distress were significantly, positively correlated
with each other (rs ranged from .64 to .89, all p<.001). Given this, the items were
combined to create a composite “total” distress score. To maintain consistency across
measures and to aid interpretation of findings, the individual distress scores were
averaged together to create a total score that ranged from 0 to 9, with higher scores still
indicative of greater distress. Coefficient alpha for the total distress score was 0.90. The
average total distress score was 4.09 ± 2.97.
Longitudinal Analyses for Unconditional Multilevel Models
The panel plots in Figures 3.1, 3.2 and 3.3 show the within-person distribution for
social support, social constraint, and distress, respectively. As shown, for each of these
variables, there was relatively low variability throughout the daily assessment.
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Table 3.1 displays the results from the unconditional growth model for social
support and social constraint, and Table 3.2 shows the results for distress. On the first day
of the daily assessment, participants’ average level of social support was 5.69 (SE=.51;
p<.001), their average level of social constraint was 2.21 (SE=.36; p<.001), and their
average level of distress was 4.25 (SE=.44; p<.001), all on a 0 to 9 scale (see the Fixed
Effects for “Intercept”). On average, participants’ level of social support, social
constraint, and distress did not significantly change over time (see the Fixed Effects for
“Time”). However, a significant random effect of intercept was found for each of these
variables, which indicates participants’ starting level of social support, social constraint,
and distress differed across people (see the Random Effects for “Intercept”). For each
model, no significant individual variability in slopes was identified (see the Random
Effects for “Time”). Finally, it was also found that an individual’s level of distress on the
first day was related to his or her change in distress over time (r=.06, p=.01). This means
that distress increased more over time among individuals with higher distress during the
first day. In contrast to distress, an individual’s level of social support and social
constraint on the first day was not associated with changes in his or her respective social
support and social constraint over time (r=.04, p=.16 and r=.03, p=.18).
Longitudinal Analyses for Conditional Multilevel Models
For each conditional multilevel model, person-centered mean scores were used
for each predictor and time was centered at the mid-point (i.e., day 15), given that the
dependent variables did not change significantly over time in the unconditional models.
Average level of social support was unrelated to distress on a typical day (p=.42),
and average level of distress was unrelated to social support on a typical day (p=.36); see
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the Fixed Effects for “Social Support” and “Distress” in Table 3.3. In contrast, a
significant, positive association was found between participants’ average level of social
constraint and distress on a typical day, with this effect observed in both directions (see
the Fixed Effects for “Social Constraint” and “Distress” in Table 3.4). The model for
distress suggest that for a person who is one unit higher in social constraint on average,
her or his typical level of distress on the 0 to 9 scale increases by .83 units (SE=.16;
p<.001). Similarly, the model for social constraint indicates that for a person who is one
unit higher in average distress, her or his typical level of social constraint on that same
scale increases by .53 units (SE=.10; p<.001). Social support and social constraint were
unrelated to change in distress and distress was unrelated to change in social support and
social constraint (p-values ranged from .21 to .94); see the Fixed Effects for “Social
Support by Time” and “Distress by Time” in Table 3.3, and for “Social Constraint by
Time” and “Distress by Time” in Table 3.4.
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Table 3.1
Parameter Estimates for the Linear Growth Model of Social Functioning
Social Support
95% CI
Fixed Effects (intercept,
slopes)
Intercept (level at day 0)
Time1
Random Effects
Level 2 (between-person)
Intercept
Time
Level 1 (within-person)
Residual
Autocorrelation
Social Constraint

Estimate (SE)

t(36)

p

Lower

Upper

5.69 (0.51)
0.00 (0.01)

11.15
0.31

.00
.78

Estimate (SE)

z

p

8.98 (2.26)
-0.04 (0.04)

3.98
-1.20

.00
.23

5.48
-0.12

14.70
0.03

2.50 (0.15)
0.30 (0.04)

16.74
7.16

.00
.00

2.22
0.21

2.81
0.38

4.66
6.73
-0.02
0.03
95% CI
Lower Upper

95% CI
Fixed Effects (intercept,
slopes)
Intercept (level at day 0)
Time1

Estimate (SE)

t(36)

p

2.21 (0.36)
-0.01 (0.01)

6.13
-0.46

.00
.65

Lower

1.48
2.94
-0.03
0.02
95% CI
Lower Upper

Random Effects
Estimate (SE)
z
p
Level 2 (between-person)
Intercept
4.12 (1.13)
3.63
.00
2.40
Time
-0.01 (0.02)
-0.34
.74
-0.05
Level 1 (within-person)
Residual
3.47 (0.18)
19.16
.00
3.13
Autocorrelation
0.10 (0.04)
2.53
.01
0.02
Note. CI = confidence interval; 1 Time is coded where Day 1 = 0 … Day 30 = 29
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Upper

7.07
0.04
3.84
0.18

Table 3.2
Parameter Estimates for the Linear Growth Model of Distress
95% CI
Fixed Effects (intercept,
slopes)
Intercept (level at day 0)
Time1

Estimate (SE)

t(36)

p

4.25 (0.44)
0.13 (0.01)

9.63
0.93

.00
.36

Lower

Upper

3.36
5.15
-0.01
0.04
95% CI
Lower Upper

Random Effects
Estimate (SE)
z
p
Level 2 (between-person)
Intercept
6.61 (1.71)
3.88
.00
3.99
10.96
Time
-0.02 (0.04)
-0.49
.63
-0.10
0.06
Level 1 (within-person)
Residual
1.98 (0.12)
15.92
.00
1.75
2.24
Autocorrelation
0.37 (0.04)
9.69
.00
0.29
0.44
1
Note. CI = confidence interval; Time is coded where Day 1 = 0 … Day 30 = 29
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Table 3.3
Parameter Estimates for the Linear Growth Model of Distress as a Function of Social
Support and Vice Versa
Social Support à Distress
95% CI
Fixed Effects (intercept,
Estimate (SE)
t(34)
p
Lower
Upper
slopes)
Intercept (level at day 15)
5.15 (0.99)
5.20
.00
3.14
7.17
1
Time
-0.00 (0.03)
-0.12
.90
-0.06
0.06
Social Support
-0.13 (0.15)
-0.82
.42
-0.44
0.19
Social Support by Time
0.00 (0.01)
0.62
.54
-0.01
0.01
95% CI
Random Effects
Estimate (SE)
z
p
Lower
Upper
Level 2 (between-person)
Intercept
6.93 (1.75)
3.97
.00
4.23
11.37
Time
0.04 (0.04)
1.01
.32
-0.04
0.12
Level 1 (within-person)
Residual
1.98 (0.12)
15.93
.00
1.75
2.24
Autocorrelation
0.37 (0.04)
9.68
.00
0.29
0.44
Distress à Social Support
95% CI
Fixed Effects (intercept,
slopes)
Intercept (level at day 15)
Time1
Distress
Distress by Time

Estimate (SE)

t(34)

p

6.47 (0.94)
0.02 (0.02)
-0.17 (0.18)
-0.00 (0.01)

6.87
0.85
-0.91
-0.84

.00
.40
.36
.41

z

p

4.07
-0.55

.00
.58

5.06
-0.08

13.25
0.05

14.91
7.16

.00
.00

2.22
0.21

2.81
0.38

Random Effects
Estimate (SE)
Level 2 (between-person)
Intercept
8.19 (2.01)
Time
-0.02 (0.03)
Level 1 (within-person)
Residual
2.50 (0.15)
Autocorrelation
0.30 (0.04)
1
Note. Time is centered such that Day 15 = 0
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Lower

Upper

4.56
8.37
-0.03
0.06
-0.54
0.20
-0.01
0.01
95% CI
Lower Upper

Table 3.4
Parameter Estimates for the Linear Growth Model of Distress as a Function of Social
Constraint and Vice Versa
Social Constraintà Distress
95% CI
Fixed Effects (intercept,
Estimate (SE)
t(34)
p
Lower
Upper
slopes)
Intercept (level at day 15)
2.62 (.48)
5.40
.00
1.63
3.60
1
Time
0.01 (.02)
0.55
.58
-0.03
0.05
Social Constraint
0.83 (.16)
5.10
.00
0.50
1.16
Social Constraint by Time
0.00 (.01)
0.08
.94
-0.01
0.01
95% CI
Random Effects
Estimate (SE)
z
p
Lower
Upper
Level 2 (between-person)
Intercept
3.88 (1.02)
3.79
.00
2.31
6.50
Time
0.03 (0.03)
1.05
.29
-0.03
0.09
Level 1 (within-person)
Residual
1.98 (0.12)
15.91
.00
1.75
2.24
Autocorrelation
0.37 (0.04)
9.69
.00
0.29
0.44
Distressà Social Constraint
95% CI
Fixed Effects (intercept,
slopes)
Intercept (level at day 15)
Time1
Distress
Distress by Time

Estimate (SE)

t(34)

p

-0.17 (0.51)
-0.02 (0.02)
0.53 (0.10)
0.01 (0.00)

-0.34
-1.27
5.28
1.27

.74
.16
.00
.21

z

p

3.77
-0.50

.00
.62

1.34
-0.04

3.80
0.02

19.15
2.57

.00
.01

3.13
0.02

3.85
0.18

Random Effects
Estimate (SE)
Level 2 (between-person)
Intercept
2.26 (0.60)
Time
-0.01 (0.02)
Level 1 (within-person)
Residual
3.47 (0.18)
Autocorrelation
0.11 (0.04)
1
Note. Time is centered such that Day 15 = 0
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Lower

Upper

-1.21
0.87
-0.06
0.01
0.32
0.74
-0.00
0.01
95% CI
Lower
Upper

Figure 3.1
Panel Plots of the 30-Day Time Course of Social Support
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Figure 3.2
Panel Plots of the 30-Day Time Course of Social Constraint
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Figure 3.3
Panel Plots of the 30-Day Time Course of Distress
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Chapter Four: Discussion
Drawing from a conceptual model where the sub-factors of QOL are interdependent, this study explored the nature and trajectory of social functioning and distress
in recently diagnosed cancer survivors, and how these variables are related over time. In a
complex fashion, the average baseline level of social functioning for this sample was both
similar to, and different from, what is generally found in the cancer survivorship
literature. The average level of social support (SSQ) in this sample of cervical and
head/neck cancer survivors is similar to previous studies with breast cancer survivors
(Osborne & Sinclair, 2004), advanced cancer survivors (Applebaum et al., 2014), and
cancer survivors who smoked at time of diagnosis (Yang et al., 2013). The latter two
comparison samples are noteworthy given the large proportion of participants with
advanced disease, and the fact that all participants were smokers around the time of their
diagnosis. As it pertains to social constraint (SCS), however, it would appear that
participants reported higher levels than what was found in studies with gynecological and
prostate cancer survivors (Zakowski et al., 2003; Zakowski, Ramati, Morton, Johnson, &
Flanigan, 2004). Yet, no direct comparison of social constraint can be performed due to
no previous studies having restricted their sample to participants with a recent cancer
diagnosis or to only cervical or head/neck cancer survivors. Overall, it seems this
sample’s experience of social support is comparable to that found in other cancer samples
while their experience of social constraint may be more pronounced.
As it pertains to their average baseline level of distress, participants reported
similar levels of distress on the modified DT as what is found in prior studies with
recently diagnosed head/neck cancer survivors (Buchmann, Conlee, Hunt, Agarwal, &
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White, 2013; Lewis, Salins, Kadam, & Rao, 2013). In particular, there was a close
alignment with a study of head/neck cancer survivors who were undergoing radiotherapy
(Lewis et al., 2013). In contrast, when compared to studies of colon and prostate cancer
survivors, participants in this study generally reported greater distress (Chambers et al.,
2014; Patel et al., 2011). The finding of greater distress in the current sample is supported
by a large study that evaluated level of distress by type of cancer diagnosis (Zabora et al.,
2001). In Zabora and colleagues study (2001), head/neck cancer survivors were among
the most distressed cancer survivors, which could be explained by the very high symptom
burden and life disruption due to the site of the cancer and the grueling nature of its
treatment. It should be noted, however, that in that same study gynecological cancer
survivors (which includes cervical cancer survivors) had one of the lowest levels of
distress. Thus, the relatively high level of distress observed here on the DT might be a
result of the sample being primarily composed of head/neck as opposed to cervical cancer
survivors. Of course, the DT was not the only measure of distress in this study. At
baseline, participants’ average anxiety and depression subscale scores (HADS) were
higher than in a previous study with head/neck cancer survivors (Pandey, Devi, Thomas,
Kumar, & Ramdas, 2007), though it should be noted that the other study had a smaller
percent of survivors with advanced cancer. Similarly, as indexed by their average HADS
total score, participants reported greater distress when compared to other studies with
recently diagnosed cancer survivors (Patel et al., 2011; Stafford et al., 2014). In sum, this
sample of recently diagnosed cervical and head/neck cancer survivors reported a baseline
level of distress that is higher than cancer survivors in general, but perhaps what one
would expect for cancer survivors with advanced disease and active treatment.
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It was expected that two distinct aspects of social functioning (namely, social
support and social constraint) would show different patterns of change during the 30-day
daily assessment. Given that social support is often an intentional act, a reduction in
social support might occur when survivors are believed to be doing better or have
finished treatment and/or when supporters need to resume or reprioritize their own
responsibilities. In contrast, because social constraint oftentimes happens unintentionally,
supporters might routinely engage in socially constraining ways without full awareness,
and in the absence of survivors calling direct attention to the behavior, this pattern of
social interaction could continue indefinitely. Taken together, it was thought that as time
passed, on average, participants would report less social support with no change in social
constraint. Mixed support was found for the aforementioned hypotheses, as neither social
support nor social constraint changed significantly over time. In general, previous
longitudinal studies of cancer survivors’ social functioning–studies that usually focus on
the domain of social support–have found that social functioning tends to stay the same
(Badr, Pasipanodya, & Laurenceau, 2013; Berg et al., 2008; Milbury, Badr, & Carmack,
2012; Zhou et al., 2010) or decline (De Leeuw et al., 2000; Salonen et al., 2012;
Zakowski et al., 2004) over time. It should be noted, however, that nearly all prior
longitudinal studies in this area rely on assessments that are spaced weeks, months, or
even years apart, and it may be improper to compare and contrast study findings across
arguably disparate methods. Worth mention then is that the results of this study also
converge with those of two prior studies that used daily assessments in cancer survivors.
Specifically, Berg and colleagues found that couples’ level of collaborative coping (i.e.,
couples’ active engagement in pooling resources, joint problem solving, and coping) did
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not change over time and Badr and colleagues’ study found cancer survivors’ perceptions
of social constraint (i.e., avoiding speaking to ones partner about ones thoughts and
feelings related to cancer) also did not change over time (Badr et al., 2013; Berg et al.,
2008). That said, it is important to highlight that social support and constraint in these
studies were specific to married cancer survivors, and the period of observation was
much shorter than what is used here (14 days) (Badr et al., 2013; Berg et al., 2008). Thus,
the current findings give further support to the stability of social functioning over time
and suggest this finding is not specific to married cancer survivors, who one might expect
to have a more reliable source of support/constraint. In summary, while it is possible that
the “null” results observed here are due to the 30-day window being too short a time
period to see meaningful changes in social functioning, it is also possible that social
support and constraint do not change significantly in the acute period after cancer
diagnosis.
Similar to social functioning, the extent of participants’ distress (3-item total score)
did not change significantly over time. This finding was consistent across anxiety
symptoms, depressive symptoms, and overall distress when evaluated independently
using a series of unconditional multilevel models (data not shown). No significant
changes were expected given that participants were recently diagnosed with cancer
and/or in treatment, a period of time that is well established to be associated with at least
modest distress levels (Andrykowski et al., 2008; Carlson, Waller, Groff, Giese-davis, &
Bultz, 2013; Zabora et al., 2001). Thus, it was expected that while some days would be
“good,” others would be “bad,” and overall, there would be no change over time. Other
daily assessment studies with cancer survivors have similarly found that participants
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individual and overall psychological functioning, does not change significantly over time
(Berg et al., 2008; Sherliker & Steptoe, 2000). For example, the experience of negative
emotion in prostate cancer survivors (who for the most part were recently diagnosed) did
not change over a 14-day period (Berg et al., 2008), and recently diagnosed metastatic
cancer survivors’ reports of psychological well-being also did not change across four
weeks of treatment (Sherliker & Steptoe, 2000). More traditional longitudinal studies
have found conflicting results related to cancer survivors’ long-term psychological
functioning, such that at the present time, no singular pattern of change can be established
across individuals (Carlson et al., 2013; de Graeff et al., 2000a; De Leeuw et al., 2000;
Ferrandina et al., 2012; Hammerlid, Silander, Hornestam, & Sullivan, 2001; Mantegna et
al., 2013; Neilson et al., 2010). As it pertains to head/neck and cervical cancer survivors
specifically, some studies show an increase in distress (Neilson et al., 2010), others show
a decrease in distress (De Leeuw et al., 2000), and still others show no change in distress
(de Graeff et al., 2000a; Neilson et al., 2010). Overall, and akin to the results for social
functioning, the “null” results for psychological functioning could be attributed to the
study’s methodology or to head/neck and cervical cancer survivors simply not
experiencing any meaningful changes in distress so soon after cancer diagnosis.
In a QOL framework where the sub-factors are inter-dependent, it is expected that
disruption (or improvement) in one QOL factor will negatively (or positively) affect other
QOL factors (Bloom et al., 2007). Thus, a bidirectional, longitudinal relationship between
social functioning and distress was hypothesized. In short, there was only modest support
for this hypothesis. On the one hand, social constraint and distress did demonstrate a
significant bidirectional relationship; no such relationship was observed for social support
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and distress. On the other hand, there was no evidence (in either direction) of a
longitudinal relationship between either social constraint or social support and distress.
This means that while there was support for a connection between social constraint and
distress on a typical day, there was no evidence that a change in distress from one day to
the next was dependent upon a change in social constraint or vice versa. The lack of a
longitudinal association is most easily explained by the fact that there was little to no
change in these variables during the study period, which of course, makes change very
difficult to predict.
It is important to consider these results in light of prior research. To date, more
studies with cancer survivors have evaluated the longitudinal relationship between social
support and distress (Alferi, Carver, Antoni, Weiss, & Durán, 2001; Badr, Laurenceau,
Schart, Basen-Engquist, & Turk, 2010; Berg et al., 2008; Devine, Parker, Fouladi, &
Cohen, 2003; Luszczynska et al., 2013; Roberts, Lepore, & Helgeson, 2006; Schroevers
et al., 2003; Zhou et al., 2010) than social constraint and distress (Pasipanodya et al.,
2012; Zakowski et al., 2004). Furthermore, of the available longitudinal studies, only
three have investigated these relationships through daily assessment, and in all cases only
unidirectional relationships were tested (e.g., social support predicts distress, Badr et al.,
2010; Berg et al., 2008; Pasipanodya et al., 2012). Across studies, social support shows
an inconsistent relationship with distress (Carpenter, Fowler, Maxwell, & Andersen,
2010; de Graeff et al., 2000a; De Leeuw et al., 2000; Naughton et al., 2002; Schmidt &
Andrykowski, 2004; Smith et al., 2012) while social constraint is consistently, positively
correlated with distress (Badr et al., 2013; Chambers et al., 2015; Cordova et al., 2001;
Eton, Lepore, & Helgeson, 2001; Lepore & Helgeson, 1998; Nenova, Duhamel, Zemon,
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Rini, & Redd, 2013; Schmidt & Andrykowski, 2004; Zakowski et al., 2003). In the few
head-to-head comparisons, social constraint has shown a stronger relationship with
distress than social support (Eton et al., 2001; Nenova et al., 2013; Schmidt &
Andrykowski, 2004), possibly because its effect is universal. In other words, constraining
behavior is detrimental to any and all cancer survivors, such that a lot of constraint is
always “bad” and little to no constraint is always “good.” Similarly, the experience of
distress (because it is usually perceived as “bad”) might incite social constraint from
others. In contrast to social constraint, the modest role for social support in general could
be because its receipt is psychologically beneficial for some while harmful for others (De
Leeuw et al., 2000), essentially washing out its effect at the sample or population level.
Even if that is the case, though, one might still expect a within-person association
between distress and social support, as is sometimes found (Badr et al., 2010). In sum, a
bidirectional positive relationship was found for social constraint and distress, and
suggests that opportunities for cancer survivors to share their emotions and experiences
may be important for distress management and likewise that the experience of distress
may contribute to a “closed” or “constraining” social environment.
To our knowledge, no study published to date involves the same intensity and
duration of naturalistic observations of social and/or psychological functioning after
cancer diagnosis. Of the few other daily assessment studies in this area, they either
include a smaller sample size than what was used here (Sherliker & Steptoe, 2000),
involve a shorter period of observation, are not restrictive to those newly diagnosed with
cancer (Badr et al., 2013; Berg et al., 2008), or do not evaluate the trajectory of change in
the outcome (Badr et al., 2010; Fagundes, Berg, & Wiebe, 2012; Pasipanodya et al.,
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2012). In addition, it is important to highlight that nearly half of participants in this study
had stage IV disease, whereas other daily assessment studies only include survivors with
less advanced disease (e.g., Belcher et al., 2011; Berg et al., 2008; Pasipanodya et al.,
2012). Thus, this study attempts to tackle many of the methodological shortcomings of
prior studies.
Despite its innovation and methodological rigor, this study is not without its
limitations. First, the sample size is small, even for a data analytic approach that is
designed to capitalize on the richness of intensive longitudinal data collection. That said,
given the expectation of 30 consecutive days of assessment, the high symptom burden
and arduous nature of cancer treatment, plus the stigma sometimes associated with
smoking-related cancers, we anticipated a small sample size with a high degree of
dropout. Nonetheless, the small sample size prohibited inclusion of covariates in the
multivariate models, and it also prohibited the inclusion of both social support and social
constraint as predictors of distress in the same model. Second, given that daily
assessment studies require brevity for compliance, some of the key variables were
measured with only one item, which is not ideal for complex psychosocial constructs.
There is, of course, precedence for single item measures in daily assessment studies (e.g.,
Badr et al., 2010, 2013; Berg et al., 2008; Pasipanodya et al., 2012; Searles et al., 2002;
Zhou et al., 2009), and more importantly, all of the single-item measures in this study
were significantly associated with their respective multi-item measures at baseline, which
suggest the single-item measures are targeting the same construct. Third, the null findings
related to social support could be attributed to it being measured as too general as
construct, as social support is known to be multidimensional (Dakof & Taylor, 1990;
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Nausheen et al., 2009; Schroevers et al., 2010). Future studies should therefore include
more specific dimensions of social support in an attempt to determine which, if any,
dimensions change over time and are more strongly associated with distress (e.g.,
availability of support if needed, extent of social network). Fourth, the DT measure was
modified from a 0-10 scale to 0-9 scale to avoid errors in data capture within the IVR
system (i.e., a “10” is recognized/entered as a “1”). Due to this modification, the direct
comparison between the DT results of this study and those of past and future studies that
use the DT is somewhat limited. Fifth, participants who had the highest amounts of
missing data during the daily assessment reported the highest anxiety levels at baseline,
which could have implications for the generalizability of the results. However, given that
restricted maximum likelihood estimator uses all available data to estimate any missing
data, it is expected that the estimated data are a good proxy for the real values. Lastly,
participants’ demographic and clinical characteristics may limit the generalizability of
study findings.
In summary, this study provides a greater understanding of two central aspects of
QOL during the acute period of cancer diagnosis and treatment, namely social and
psychological functioning. The results showed little change in social support, social
constraint, and distress among recently diagnosed head/neck and cervical cancer
survivors, results that may generalize to other cancer populations, in particular those with
advanced disease and ensuing treatment. Of course, it might be the case that meaningful
changes in social functioning and distress are in fact present among recently diagnosed
cancer survivors, it is just that these changes are confined to a single day. If so,
observation of change would require ecological momentary assessment, which was not

47

used here. It might also be the case that change in these constructs unfolds more slowly,
over weeks or even months, in which case the more traditional approaches to longitudinal
studies would be appropriate. For these reasons, it is not yet possible to “close the book”
on changes in social functioning and distress after cancer diagnosis. Future studies are
still needed to unpack the complexity of how cancer diagnosis might impact these QOL
components. In addition to the results related to change over time (or the lack thereof),
this study also showed that for a typical day, social constraint–but not social support–
predicts distress and vice versa. These findings underscore the need to consider both
positive and negative aspects of cancer survivors’ social functioning in attempts to
predict or explain their psychological functioning, at least as it pertains to the outcome of
distress. Furthermore, these findings support existing theories, which purport that social
functioning is multidimensional and its sub-components differentially impact distress. In
conclusion, this study further highlights the importance of social functioning and distress
after cancer diagnosis, and raises the possibility that improvements in one QOL domain
may be achieved through improvements in another, related QOL domain.
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